Baxter International Inc. is a global healthcare company that develops and supplies medical innovations, devices and therapies used across hospitals, clinics, physician's offices and patients' homes. Founded in 1931, the company operates in markets worldwide and reports that its portfolio is relied upon daily by millions of patients and healthcare providers. Its technical domains span medical devices, infusion and intravenous solutions, injectable drug delivery technologies, connected healthcare solutions, renal care technology and clinical care solutions.
The company's product portfolio includes intravenous solutions - the first commercially produced, and a foundational part of its history - alongside acute care therapies used from the ER to the ICU, nutritional care therapies, renal care therapies, surgical care therapies used in the OR, advanced injectable technologies and a range of medical devices. Its connected solutions portfolio is described as supporting smarter, more personalised care for patients and providers.
Baxter's products are present throughout the care continuum, from the pharmacy and the ICU to home healthcare settings, and its stated industry coverage includes hospitals, emergency care, surgery, renal care, clinical nutrition, medical devices and pharmaceuticals and injectables. The company describes a culture centred on pioneering medical innovation, a patient- and provider-focused mission, and collaboration in redefining how care is delivered.
